组织因子途径抑制物功能受损与首次无诱因的深静脉血栓形成患者复发性静脉血栓栓塞相关。 - Suppr | 超能文献

Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis.

作者信息

Winckers K, Ten Cate-Hoek A J, Beekers K C M M, Erkens P, Hamulyák K, Ten Cate H, Hackeng T M

出版信息

J Thromb Haemost. 2012 Oct;10(10):2208-11. doi: 10.1111/j.1538-7836.2012.04884.x.

DOI:10.1111/j.1538-7836.2012.04884.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis.组织因子途径抑制物功能受损与首次无诱因的深静脉血栓形成患者复发性静脉血栓栓塞相关。

J Thromb Haemost. 2012 Oct;10(10):2208-11. doi: 10.1111/j.1538-7836.2012.04884.x.

2

Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.促血栓形成的纤维蛋白凝块表型与抗凝治疗中断后复发性肺栓塞相关。

Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):365-373. doi: 10.1161/ATVBAHA.116.308253. Epub 2016 Dec 29.

3

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.异常的 Protac 诱导凝血抑制显色测定结果与复发性静脉血栓栓塞风险增加相关。

J Thromb Thrombolysis. 2010 Aug;30(2):215-9. doi: 10.1007/s11239-010-0479-z.

4

The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.特发性静脉血栓栓塞患者的长期复发风险：一项观察性队列研究。

J Thromb Haemost. 2016 Dec;14(12):2402-2409. doi: 10.1111/jth.13524. Epub 2016 Nov 19.

5

Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.总组织因子途径抑制剂与静脉血栓形成。血栓栓塞病因的纵向研究。

Thromb Haemost. 2010 Aug;104(2):207-12. doi: 10.1160/TH09-10-0693. Epub 2010 Apr 29.

6

Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study.血脂水平与复发性静脉血栓栓塞风险：来自 MEGA 随访研究的结果。

J Thromb Haemost. 2017 Apr;15(4):695-701. doi: 10.1111/jth.13640. Epub 2017 Feb 25.

7

Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.在 PROLONG 研究中，首次特发性深静脉血栓形成后抗凝治疗停药后复发的危险因素：单纯残留静脉阻塞，以及与 D-二聚体联合存在。

Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. doi: 10.1016/j.ejvs.2009.11.022. Epub 2010 Jan 19.

8

Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.在无因子 V 莱顿突变的情况下，凝血酶生成和活化蛋白 C 抵抗与 18-65 岁女性复发性静脉血栓栓塞风险相关。

Thromb Haemost. 2011 Nov;106(5):901-7. doi: 10.1160/TH11-04-0254. Epub 2011 Sep 22.

9

Thrombin generation as an intermediate phenotype for venous thrombosis.凝血酶生成作为静脉血栓形成的中间表型。

Thromb Haemost. 2010 Jan;103(1):114-22. doi: 10.1160/TH09-06-0356. Epub 2009 Nov 13.

10

Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.抗凝的最佳持续时间。诱发与非诱发静脉血栓栓塞以及辅助性易栓症和影像学检查的作用。

Thromb Haemost. 2015 Jun;113(6):1210-5. doi: 10.1160/TH14-04-0396. Epub 2014 Aug 14.

引用本文的文献

1

Risk of First Venous Thrombosis by Comparing Different Thrombin Generation Assay Conditions: Results from the MEGA Case-control Study.通过比较不同凝血酶生成检测条件评估首次静脉血栓形成风险：MEGA病例对照研究结果

TH Open. 2025 Mar 19;9:a25346123. doi: 10.1055/a-2534-6123. eCollection 2025.

2

Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.健康志愿者体内的血小板全长组织因子途径抑制物-α不受性别或激素使用情况的影响。

PLoS One. 2017 Feb 3;12(2):e0168273. doi: 10.1371/journal.pone.0168273. eCollection 2017.

3

Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.2号染色体基因间区域的单核苷酸多态性与组织因子途径抑制物血浆水平及静脉血栓栓塞相关。

J Thromb Haemost. 2016 Oct;14(10):1960-1970. doi: 10.1111/jth.13431. Epub 2016 Sep 17.